Feasibility of retroperitoneal pelvic lymph node exploration in cervical carcinoma. Assessment of morbidity in 33 cases treated by combined radio-surgery or definitive radiotherapy.
Identifieur interne : 005128 ( PubMed/Corpus ); précédent : 005127; suivant : 005129Feasibility of retroperitoneal pelvic lymph node exploration in cervical carcinoma. Assessment of morbidity in 33 cases treated by combined radio-surgery or definitive radiotherapy.
Auteurs : M. Bolla ; J. Salvat ; R. Sarrazin ; J F Dyon ; E. Berland ; M H Schmidt ; J. De Cornelier ; T D Quoc ; I. RolachonSource :
- Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [ 0167-8140 ] ; 1996.
English descriptors
- KwdEn :
- Adult, Aged, Brachytherapy, Combined Modality Therapy, Endoscopes, Endoscopy (methods), Feasibility Studies, Female, Humans, Hysterectomy (methods), Lymphatic Irradiation, Lymphatic Metastasis, Middle Aged, Morbidity, Prognosis, Survival Rate, Uterine Cervical Neoplasms (pathology), Uterine Cervical Neoplasms (radiotherapy), Uterine Cervical Neoplasms (surgery).
- MESH :
- methods : Endoscopy, Hysterectomy.
- pathology : Uterine Cervical Neoplasms.
- radiotherapy : Uterine Cervical Neoplasms.
- surgery : Uterine Cervical Neoplasms.
- Adult, Aged, Brachytherapy, Combined Modality Therapy, Endoscopes, Feasibility Studies, Female, Humans, Lymphatic Irradiation, Lymphatic Metastasis, Middle Aged, Morbidity, Prognosis, Survival Rate.
Abstract
Laparoscopic modalities by selective biopsies permit a better assessment of the pelvic lymph nodes status than imaging procedures in cervix carcinoma. They could enable the radiation oncologist to adapt the target volume of external irradiation, provided the feasibility of such procedures is good and the toxicity reduced as much as possible.
PubMed: 8940750
Links to Exploration step
pubmed:8940750Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Feasibility of retroperitoneal pelvic lymph node exploration in cervical carcinoma. Assessment of morbidity in 33 cases treated by combined radio-surgery or definitive radiotherapy.</title>
<author><name sortKey="Bolla, M" sort="Bolla, M" uniqKey="Bolla M" first="M" last="Bolla">M. Bolla</name>
<affiliation><nlm:affiliation>Service de Cancérologie-Radiothérapie, CHU A. Michallon BP 217, Grenoble, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Salvat, J" sort="Salvat, J" uniqKey="Salvat J" first="J" last="Salvat">J. Salvat</name>
</author>
<author><name sortKey="Sarrazin, R" sort="Sarrazin, R" uniqKey="Sarrazin R" first="R" last="Sarrazin">R. Sarrazin</name>
</author>
<author><name sortKey="Dyon, J F" sort="Dyon, J F" uniqKey="Dyon J" first="J F" last="Dyon">J F Dyon</name>
</author>
<author><name sortKey="Berland, E" sort="Berland, E" uniqKey="Berland E" first="E" last="Berland">E. Berland</name>
</author>
<author><name sortKey="Schmidt, M H" sort="Schmidt, M H" uniqKey="Schmidt M" first="M H" last="Schmidt">M H Schmidt</name>
</author>
<author><name sortKey="De Cornelier, J" sort="De Cornelier, J" uniqKey="De Cornelier J" first="J" last="De Cornelier">J. De Cornelier</name>
</author>
<author><name sortKey="Quoc, T D" sort="Quoc, T D" uniqKey="Quoc T" first="T D" last="Quoc">T D Quoc</name>
</author>
<author><name sortKey="Rolachon, I" sort="Rolachon, I" uniqKey="Rolachon I" first="I" last="Rolachon">I. Rolachon</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1996">1996</date>
<idno type="RBID">pubmed:8940750</idno>
<idno type="pmid">8940750</idno>
<idno type="wicri:Area/PubMed/Corpus">005128</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005128</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Feasibility of retroperitoneal pelvic lymph node exploration in cervical carcinoma. Assessment of morbidity in 33 cases treated by combined radio-surgery or definitive radiotherapy.</title>
<author><name sortKey="Bolla, M" sort="Bolla, M" uniqKey="Bolla M" first="M" last="Bolla">M. Bolla</name>
<affiliation><nlm:affiliation>Service de Cancérologie-Radiothérapie, CHU A. Michallon BP 217, Grenoble, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Salvat, J" sort="Salvat, J" uniqKey="Salvat J" first="J" last="Salvat">J. Salvat</name>
</author>
<author><name sortKey="Sarrazin, R" sort="Sarrazin, R" uniqKey="Sarrazin R" first="R" last="Sarrazin">R. Sarrazin</name>
</author>
<author><name sortKey="Dyon, J F" sort="Dyon, J F" uniqKey="Dyon J" first="J F" last="Dyon">J F Dyon</name>
</author>
<author><name sortKey="Berland, E" sort="Berland, E" uniqKey="Berland E" first="E" last="Berland">E. Berland</name>
</author>
<author><name sortKey="Schmidt, M H" sort="Schmidt, M H" uniqKey="Schmidt M" first="M H" last="Schmidt">M H Schmidt</name>
</author>
<author><name sortKey="De Cornelier, J" sort="De Cornelier, J" uniqKey="De Cornelier J" first="J" last="De Cornelier">J. De Cornelier</name>
</author>
<author><name sortKey="Quoc, T D" sort="Quoc, T D" uniqKey="Quoc T" first="T D" last="Quoc">T D Quoc</name>
</author>
<author><name sortKey="Rolachon, I" sort="Rolachon, I" uniqKey="Rolachon I" first="I" last="Rolachon">I. Rolachon</name>
</author>
</analytic>
<series><title level="j">Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</title>
<idno type="ISSN">0167-8140</idno>
<imprint><date when="1996" type="published">1996</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Brachytherapy</term>
<term>Combined Modality Therapy</term>
<term>Endoscopes</term>
<term>Endoscopy (methods)</term>
<term>Feasibility Studies</term>
<term>Female</term>
<term>Humans</term>
<term>Hysterectomy (methods)</term>
<term>Lymphatic Irradiation</term>
<term>Lymphatic Metastasis</term>
<term>Middle Aged</term>
<term>Morbidity</term>
<term>Prognosis</term>
<term>Survival Rate</term>
<term>Uterine Cervical Neoplasms (pathology)</term>
<term>Uterine Cervical Neoplasms (radiotherapy)</term>
<term>Uterine Cervical Neoplasms (surgery)</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Endoscopy</term>
<term>Hysterectomy</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Uterine Cervical Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Uterine Cervical Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Uterine Cervical Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Brachytherapy</term>
<term>Combined Modality Therapy</term>
<term>Endoscopes</term>
<term>Feasibility Studies</term>
<term>Female</term>
<term>Humans</term>
<term>Lymphatic Irradiation</term>
<term>Lymphatic Metastasis</term>
<term>Middle Aged</term>
<term>Morbidity</term>
<term>Prognosis</term>
<term>Survival Rate</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Laparoscopic modalities by selective biopsies permit a better assessment of the pelvic lymph nodes status than imaging procedures in cervix carcinoma. They could enable the radiation oncologist to adapt the target volume of external irradiation, provided the feasibility of such procedures is good and the toxicity reduced as much as possible.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">8940750</PMID>
<DateCreated><Year>1997</Year>
<Month>03</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted><Year>1997</Year>
<Month>03</Month>
<Day>06</Day>
</DateCompleted>
<DateRevised><Year>2005</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0167-8140</ISSN>
<JournalIssue CitedMedium="Print"><Volume>40</Volume>
<Issue>3</Issue>
<PubDate><Year>1996</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</Title>
<ISOAbbreviation>Radiother Oncol</ISOAbbreviation>
</Journal>
<ArticleTitle>Feasibility of retroperitoneal pelvic lymph node exploration in cervical carcinoma. Assessment of morbidity in 33 cases treated by combined radio-surgery or definitive radiotherapy.</ArticleTitle>
<Pagination><MedlinePgn>233-9</MedlinePgn>
</Pagination>
<Abstract><AbstractText Label="BACKGROUND AND PURPOSE" NlmCategory="OBJECTIVE">Laparoscopic modalities by selective biopsies permit a better assessment of the pelvic lymph nodes status than imaging procedures in cervix carcinoma. They could enable the radiation oncologist to adapt the target volume of external irradiation, provided the feasibility of such procedures is good and the toxicity reduced as much as possible.</AbstractText>
<AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">From June 1980 to May 1993, 52 women with a mean age of 49, underwent a retroperitoneal pelvic lymph node laparoscopic procedure for cervix carcinoma classified according to FIGO as stages IA2 (14), IB (12), IIA (6), IIB (14), IIIB (3) and IVA (3). Two techniques were used: retroperitoneoscopy (RPS) in 16 cases, and a panoramic retroperitoneal pelviscopy (PRPP) in 36 cases.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Intra-operative and post-surgical morbidity were equivalent in the two procedures. Among the 33 patients who had external irradiation, one Grade 3 urinary late morbidity (3%) due to an overtreatment was observed; no Grade 3/4 morbidity of the gastro-intestinal tract, no lymphoedema of the lower extremities, no parietal tumor cells implantation were noticed.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These procedures can be used safely to better know the prognosis and to define the pelvic lymph node planning target volume and its radiation management with accuracy.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bolla</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Service de Cancérologie-Radiothérapie, CHU A. Michallon BP 217, Grenoble, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Salvat</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Sarrazin</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>Dyon</LastName>
<ForeName>J F</ForeName>
<Initials>JF</Initials>
</Author>
<Author ValidYN="Y"><LastName>Berland</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y"><LastName>Schmidt</LastName>
<ForeName>M H</ForeName>
<Initials>MH</Initials>
</Author>
<Author ValidYN="Y"><LastName>de Cornelier</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Quoc</LastName>
<ForeName>T D</ForeName>
<Initials>TD</Initials>
</Author>
<Author ValidYN="Y"><LastName>Rolachon</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Ireland</Country>
<MedlineTA>Radiother Oncol</MedlineTA>
<NlmUniqueID>8407192</NlmUniqueID>
<ISSNLinking>0167-8140</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001918" MajorTopicYN="N">Brachytherapy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019723" MajorTopicYN="N">Endoscopes</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004724" MajorTopicYN="Y">Endoscopy</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007044" MajorTopicYN="Y">Hysterectomy</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015182" MajorTopicYN="N">Lymphatic Irradiation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009017" MajorTopicYN="N">Morbidity</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002583" MajorTopicYN="N">Uterine Cervical Neoplasms</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1996</Year>
<Month>9</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1996</Year>
<Month>9</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1996</Year>
<Month>9</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">8940750</ArticleId>
<ArticleId IdType="pii">0167814096017902</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005128 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 005128 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:8940750 |texte= Feasibility of retroperitoneal pelvic lymph node exploration in cervical carcinoma. Assessment of morbidity in 33 cases treated by combined radio-surgery or definitive radiotherapy. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:8940750" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |